BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11526486)

  • 1. Hepatocellular expression of a dominant-negative mutant TGF-beta type II receptor accelerates chemically induced hepatocarcinogenesis.
    Kanzler S; Meyer E; Lohse AW; Schirmacher P; Henninger J; Galle PR; Blessing M
    Oncogene; 2001 Aug; 20(36):5015-24. PubMed ID: 11526486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
    Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.
    Im YH; Kim HT; Kim IY; Factor VM; Hahm KB; Anzano M; Jang JJ; Flanders K; Haines DC; Thorgeirsson SS; Sizeland A; Kim SJ
    Cancer Res; 2001 Sep; 61(18):6665-8. PubMed ID: 11559531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of c-myc-induced hepatocarcinogenesis by Co-expression of transforming growth factor (TGF)-alpha in transgenic mice is associated with TGF-beta1 signaling disruption.
    Santoni-Rugiu E; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1999 Jun; 154(6):1693-700. PubMed ID: 10362794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development.
    Amendt C; Schirmacher P; Weber H; Blessing M
    Oncogene; 1998 Jul; 17(1):25-34. PubMed ID: 9671311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor (TGF)-beta1 and TGF-beta type II receptor in preneoplastic lesions during chemical hepatocarcinogenesis of rats.
    Park DY; Hwang SY; Suh KS
    Toxicol Pathol; 2001; 29(5):541-9. PubMed ID: 11695571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
    Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
    Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.
    Abou-Shady M; Baer HU; Friess H; Berberat P; Zimmermann A; Graber H; Gold LI; Korc M; Büchler MW
    Am J Surg; 1999 Mar; 177(3):209-15. PubMed ID: 10219856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
    Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
    Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
    Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
    Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.
    Baek JY; Morris SM; Campbell J; Fausto N; Yeh MM; Grady WM
    Int J Cancer; 2010 Sep; 127(5):1060-71. PubMed ID: 20020490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.
    Böttinger EP; Jakubczak JL; Roberts IS; Mumy M; Hemmati P; Bagnall K; Merlino G; Wakefield LM
    EMBO J; 1997 May; 16(10):2621-33. PubMed ID: 9184209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of hepatocarcinogenesis by phenobarbital in c-myc/TGF-alpha transgenic mice.
    Sanders S; Thorgeirsson SS
    Mol Carcinog; 2000 Jul; 28(3):168-73. PubMed ID: 10942533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
    Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
    Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
    Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
    Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
    Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic silicosis, cirrhosis, and liver tumors in mice and hamsters: studies of transforming growth factor beta expression.
    Williams AO; Knapton AD
    Hepatology; 1996 May; 23(5):1268-75. PubMed ID: 8621163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.
    Nishikawa Y; Wang M; Carr BI
    J Cell Physiol; 1998 Sep; 176(3):612-23. PubMed ID: 9699514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.